These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 8149518)

  • 1. Short-term cholesterol lowering decreases size and severity of perfusion abnormalities by positron emission tomography after dipyridamole in patients with coronary artery disease. A potential noninvasive marker of healing coronary endothelium.
    Gould KL; Martucci JP; Goldberg DI; Hess MJ; Edens RP; Latifi R; Dudrick SJ
    Circulation; 1994 Apr; 89(4):1530-8. PubMed ID: 8149518
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Changes in myocardial perfusion abnormalities by positron emission tomography after long-term, intense risk factor modification.
    Gould KL; Ornish D; Scherwitz L; Brown S; Edens RP; Hess MJ; Mullani N; Bolomey L; Dobbs F; Armstrong WT
    JAMA; 1995 Sep; 274(11):894-901. PubMed ID: 7674504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Frequency and clinical implications of fluid dynamically significant diffuse coronary artery disease manifest as graded, longitudinal, base-to-apex myocardial perfusion abnormalities by noninvasive positron emission tomography.
    Gould KL; Nakagawa Y; Nakagawa K; Sdringola S; Hess MJ; Haynie M; Parker N; Mullani N; Kirkeeide R
    Circulation; 2000 Apr; 101(16):1931-9. PubMed ID: 10779459
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High prevalence of myocardial perfusion abnormalities on positron emission tomography in asymptomatic persons with a parent or sibling with coronary artery disease.
    Sdringola S; Patel D; Gould KL
    Circulation; 2001 Jan; 103(4):496-501. PubMed ID: 11157712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical evaluation of a new concept: resting myocardial perfusion heterogeneity quantified by markovian analysis of PET identifies coronary microvascular dysfunction and early atherosclerosis in 1,034 subjects.
    Johnson NP; Gould KL
    J Nucl Med; 2005 Sep; 46(9):1427-37. PubMed ID: 16157524
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Routine Clinical Quantitative Rest Stress Myocardial Perfusion for Managing Coronary Artery Disease: Clinical Relevance of Test-Retest Variability.
    Kitkungvan D; Johnson NP; Roby AE; Patel MB; Kirkeeide R; Gould KL
    JACC Cardiovasc Imaging; 2017 May; 10(5):565-577. PubMed ID: 28017383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined intense lifestyle and pharmacologic lipid treatment further reduce coronary events and myocardial perfusion abnormalities compared with usual-care cholesterol-lowering drugs in coronary artery disease.
    Sdringola S; Nakagawa K; Nakagawa Y; Yusuf SW; Boccalandro F; Mullani N; Haynie M; Hess MJ; Gould KL
    J Am Coll Cardiol; 2003 Jan; 41(2):263-72. PubMed ID: 12535820
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Improved coronary vasodilator capacity by drug lipid lowering therapy in patients in the early stage of coronary atherosclerosis with reduced coronary reserves and moderate LDL hypercholesteremia].
    Baller D; Gleichmann U; Notohamiprodjo G; Weise R; Holzinger J; Montanus H; Betker S; Lehmann J
    Z Kardiol; 1998; 87 Suppl 2():136-44. PubMed ID: 9827472
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mechanisms of progression and regression of coronary artery disease by PET related to treatment intensity and clinical events at long-term follow-up.
    Sdringola S; Loghin C; Boccalandro F; Gould KL
    J Nucl Med; 2006 Jan; 47(1):59-67. PubMed ID: 16391188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common artifacts in PET myocardial perfusion images due to attenuation-emission misregistration: clinical significance, causes, and solutions.
    Loghin C; Sdringola S; Gould KL
    J Nucl Med; 2004 Jun; 45(6):1029-39. PubMed ID: 15181138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improvement in coronary flow reserve determined by positron emission tomography after 6 months of cholesterol-lowering therapy in patients with early stages of coronary atherosclerosis.
    Baller D; Notohamiprodjo G; Gleichmann U; Holzinger J; Weise R; Lehmann J
    Circulation; 1999 Jun; 99(22):2871-5. PubMed ID: 10359730
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New concepts and paradigms in cardiovascular medicine: the noninvasive management of coronary artery disease.
    Gould KL
    Am J Med; 1998 Jun; 104(6A):2S-17S. PubMed ID: 9684847
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A 6 month randomized, double blind, placebo controlled, multi-center trial of high dose atorvastatin on myocardial perfusion abnormalities by positron emission tomography in coronary artery disease.
    Sdringola S; Gould KL; Zamarka LG; McLain R; Garner J
    Am Heart J; 2008 Feb; 155(2):245-53. PubMed ID: 18215593
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholesterol reduction improves myocardial perfusion abnormalities in patients with coronary artery disease and average cholesterol levels.
    Mostaza JM; Gomez MV; Gallardo F; Salazar ML; Martín-Jadraque R; Plaza-Celemín L; Gonzalez-Maqueda I; Martín-Jadraque L
    J Am Coll Cardiol; 2000 Jan; 35(1):76-82. PubMed ID: 10636263
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation of pharmacological 99mTc-sestamibi myocardial perfusion imaging with poststenotic coronary flow reserve in patients with angiographically intermediate coronary artery stenoses.
    Miller DD; Donohue TJ; Younis LT; Bach RG; Aguirre FV; Wittry MD; Goodgold HM; Chaitman BR; Kern MJ
    Circulation; 1994 May; 89(5):2150-60. PubMed ID: 8181140
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Assessment of anatomic and physiological severity of single-vessel coronary artery lesions by dipyridamole echocardiography. Comparison with positron emission tomography and quantitative arteriography.
    Picano E; Parodi O; Lattanzi F; Sambuceti G; Andrade MJ; Marzullo P; Giorgetti A; Salvadori P; Marzilli M; Distante A
    Circulation; 1994 Feb; 89(2):753-61. PubMed ID: 8313564
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Myocardial perfusion scintigraphy with Tc-99m MIBI in patients with left bundle branch block: Visual quantification of the anteroseptal perfusion imaging for the diagnosis of left anterior descending artery stenosis].
    Möller J; Warwick J; Bouma H
    Cardiovasc J S Afr; 2005; 16(2):95-101. PubMed ID: 15915276
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of short-term cardiovascular conditioning and low-fat diet on myocardial blood flow and flow reserve.
    Czernin J; Barnard RJ; Sun KT; Krivokapich J; Nitzsche E; Dorsey D; Phelps ME; Schelbert HR
    Circulation; 1995 Jul; 92(2):197-204. PubMed ID: 7600651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Noninvasive assessment of coronary stenoses by myocardial perfusion imaging during pharmacologic coronary vasodilation. VIII. Clinical feasibility of positron cardiac imaging without a cyclotron using generator-produced rubidium-82.
    Gould KL; Goldstein RA; Mullani NA; Kirkeeide RL; Wong WH; Tewson TJ; Berridge MS; Bolomey LA; Hartz RK; Smalling RW
    J Am Coll Cardiol; 1986 Apr; 7(4):775-89. PubMed ID: 3485669
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of cholesterol-lowering and antioxidant therapy on endothelium-dependent coronary vasomotion.
    Anderson TJ; Meredith IT; Yeung AC; Frei B; Selwyn AP; Ganz P
    N Engl J Med; 1995 Feb; 332(8):488-93. PubMed ID: 7830729
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.